#BEGIN_DRUGCARD DB03107

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
107-95-9

# ChEBI_ID:
16958

# Chemical_Formula:
C3H7NO2

# Chemical_IUPAC_Name:
3-aminopropanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
-3.05

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
5.45E+005 mg/L (at 25 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Beta-Alanine

# HET_ID:
BAL

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)

# InChI_Key:
InChIKey=UCMIRNVEIXFBKS-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00099

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3107

# Mechanism_Of_Action:
Not Available

# Melting_Point:
200 dec °C

# Molecular_Weight_Avg:
89.0932

# Molecular_Weight_Mono:
89.047678473

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1N2J

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-3.3

# Predicted_LogS:
0.74

# Predicted_Water_Solubility:
4.94e+02 g/l

# Primary_Accession_No:
DB03107

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
239

# PubChem_Substance_ID:
46507739

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00624

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NCCC(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:55 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
3.63 (at 5 °C)

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
BX842583

# Drug_Target_1_GenBank_ID_Protein:
2113975

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
panC

# Drug_Target_1_Gene_Sequence:
>930 bp
TCAGTTTCTCCAATGTGATTCGAGGATTGCCCGGTATCCGTCCGGGCGGTCGGTGCCGGC
GAAAGTTCCGATTTCAATCGCAATGTTGTCCAGCAGCCTGGTGGTGCCAAGCCGGGCAGC
AACCAGCAGCCGACCGGAACCGTTGAGCGGCATCGGGCCAAGCCCGATATCGCGCAGCTC
CAGGTAGTCGACCGCCACGCCGGGTGCAGCGTCGAGCACCGCACGGGCGGCATCCAGCGC
GGCCTGCGCGCCAGCCGTTGCCGCATGCGCTGCGGCCGTTAGCGCCGCCGAGAGCGCGAC
GGCCGCCGCACGCTGGGCCGGGTCCAGGTAGCGGTTGCGCGACGACATCGCCAGCCCGTC
GGCTTCGCGCACGGTCGGCACGCCGACCACCGCGACATCGAGGTTGAAGTCCGCGACCAG
CTGCCGGATCAGCACCAGCTGCTGGTAGTCCTTCTCACCGAAGAACACCCGATCCGGGCG
CACGATCTGCAGCAGCTTTAGCACGACCGTCAGCACGCCGGCGAAATGGGTTGGCCGCGG
GCCGCCCTCGAGTTCGGCGGCCAACGGACCGGGTTGCACGGTGGTGCGCAGGCCGTCGGG
ATACATCGCCGCGGTAGTTGGCGTGAAAGCGATTTCCACGCCTTCGGCCCGCAGTTGCGC
CAGGTCGTCGTCCGGGGTGCGGGGATAGGCGTCGAGATCTTCCCCGGCACCGAATTGCAT
CGGGTTGACGAAGATCGACACGACGACGACCGATCCGGGCACCCGCTTGGCCGCACGCAC
CAACGCGAGGTGGCCTTCGTGCAGCGCACCCATAGTAGGCACCAACATCACTCGCCGGCC
GGTGAGTCGCAGTGCGCGACTGACATCGGCGACATCCCCCGGTGCCGAGTACACATTGAG
TTCACCGGGATGGAACGCAGGAATCGTCAT

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2532

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
32678

# Drug_Target_1_Name:
Pantoate--beta-alanine ligase

# Drug_Target_1_Number_of_Residues:
309

# Drug_Target_1_PDB_ID:
1N2O

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02569	Pantoate_ligase

# Drug_Target_1_Protein_Sequence:
>Pantoate--beta-alanine ligase
MTIPAFHPGELNVYSAPGDVADVSRALRLTGRRVMLVPTMGALHEGHLALVRAAKRVPGS
VVVVSIFVNPMQFGAGEDLDAYPRTPDDDLAQLRAEGVEIAFTPTTAAMYPDGLRTTVQP
GPLAAELEGGPRPTHFAGVLTVVLKLLQIVRPDRVFFGEKDYQQLVLIRQLVADFNLDVA
VVGVPTVREADGLAMSSRNRYLDPAQRAAAVALSAALTAAAHAATAGAQAALDAARAVLD
AAPGVAVDYLELRDIGLGPMPLNGSGRLLVAARLGTTRLLDNIAIEIGTFAGTDRPDGYR
AILESHWRN

# Drug_Target_1_Reaction:
ATP + (R)-pantoate + beta-alanine = AMP + diphosphate + (R)-pantothenate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + (R)-pantoate + beta-alanine = AMP + diphosphate + (R)-pantothenate

# Drug_Target_1_SwissProt_ID:
P0A5R0

# Drug_Target_1_SwissProt_Name:
PANC_MYCTU

# Drug_Target_1_Synonyms:
EC 6.3.2.1
Pantoate-activating enzyme
Pantothenate synthetase

# Drug_Target_1_Theoretical_pI:
5.96

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03107
